Experience with olokizumab in the treatment of polymyalgia rheumatica and giant cell arteritis: A series of cases

Autor: Alexey D. Meshkov, Alexey L. Maslyansky, Nikolay M. Bulanov, Ekaterina E. Filatova, Pavel I. Novikov, Anton V. Naumov, Olga N. Tkacheva

Publikováno v: Научно-практическая ревматология, Vol 62, Iss 4 (2024)

Glucocorticoids are the basis for the treatment of giant cell arteritis (GCA) and polymyalgia rheumatica (PMR), however, their long-term use is associated with a number of well-known side effects. Despite the fact that a significant number of patient

Externí odkaz: https://doaj.org/article/f912550e6fa242f3a260a193b19094e7

Analysis of data from the Russian AURA registry (real-world data registry on AlbUminuRia detection rate among patients with previously undiAgnosed chronic kidney disease)

Autor: M. M. Batyushin, M. A. Trubnikova, G. P. Arutyunov, E. I. Tarlovskaya, A. G. Arutyunov, D. S. Polyakov, S. Sh. Akhmedkhanov, I. G. Bakulin, I. A. Bodrievskaya, I. A. Viktorova, N. G. Vinogradova, A. S. Galyavich, N. P. Garganeeva, N. Yu. Grigorieva, S. B. Erofeeva, M. A. Kercheva, S. G. Kechedzhieva, N. A. Koryagina, S. V. Malchikova, V. A. Nevzorova, S. V. Nedogoda, M. M. Petrova, V. A. Pogrebetskaya, A. P. Rebrov, O. A. Rubanenko, E. A. Safianik, V. V. Skibitsky, E. A. Smirnova, E. A. Starovoitova, R. F. Khamitov, A. I. Chesnikova, T. M. Shabatina, I. I. Shaposhnik, A. R. Vaisberg, A. V. Aparkina, I. N. Barykina, T. I. Batluk, R. A. Bashkinov, A. T. Beybalayeva, Y. A. Belenikina, O. A. Bilevich, Zh. V. Bondareva, A. Yu. Vaskin, T. V. Vlasova, E. V. Galko, T. U. Garifullin, E. D. Gordeychuk, E. V. Grigorieva, I. V. Gubareva, L. K. Danilova, A. I. Dolgushina, E. M. Durygina, D. S. Evdokimov, N. V. Zhdankina, E. I. Zheleznyak, D. S. Zueva, D. S. Ivanova, E. Yu. Ivanchenko, M. V. Kazakovtseva, A. A. Kaznina, N. A. Karoli, D. S. Kaskaeva, Z. F. Kim, M. V. Kozlova, Y. I. Kudrinskaya, A. S. Kuznetsova, E. Yu. Levchenko, I. A. Lukonin, V. O. Lutova, N. A. Magdeeva, E. V. Makarova, N. E. Makarova, M. M. Mamontova, E. S. Melnikov, A. F. Molostvova, T. D. Naborshchikova, I. N. Nikitina, D. P. Novikova, M. V. Novikova, V. I. Pakusina, K. G. Pereverzeva, I. S. Pleshakov, Yu. G. Pokramovich, O. V. Ponomareva, E. A. Popova, N. A. Popova, E. S. Potapova, E. D. Resnyanskaya, M. Yu. Rozhkova, A. O. Rubanenko, M. D. Rudoy, A. S. Salasyuk, L. M. Salimova, V. I. Samokhina, N. Sh. Sanginova, F. I. Sattarova, A. Kh. Safina, D. P. Sirotenko, N. S. Skarzhinskaya, A. V. Skibitsky, E. I. Suchkova, L. E. Tepnadze, A. V. Fendrikova, T. E. Filatova, O. V. Filyushin, O. Yu. Chizhova, T. I. Chudinovskikh, S. S. Yakushin, E. M. Yashina

Publikováno v: Российский кардиологический журнал, Vol 29, Iss 7 (2024)

Aim. To present data from the AURA Registry (real-world data registry on AlbUminuRia detection rate among patients with previously undiAgnosed chronic kidney disease). It is important to perform population studies both to study the occurrence of mark

Externí odkaz: https://doaj.org/article/e6737166623e4811afc3782016a90baa

Features of the course of COVID-19 in patients with type 2 diabetes mellitus

Autor: Elena A. Karaseva, Vladimir A. Martynov, Tatyana E. Filatova, Viktor V. Maleev, Vladimir Yu. Grishin, Nikita S. Pronin, Elena I. Verbitskaya, Valeriia I. Popova

Publikováno v: Терапевтический архив, Vol 95, Iss 11, Pp 913-918 (2023)

Aim. To identify the features of the course of COVID-19 in patients with type 2 diabetes mellitus (T2DM), depending on the intake of hypoglycemic therapy at the prehospital stage, in conjunction with the functional state of the kidneys. Materials and

Externí odkaz: https://doaj.org/article/b0dfd335adce4ba8966c3c382ae54f34

Possibilities to raise public awareness on primary prevention of cardiovascular diseases

Autor: T. N. Zvereva, E. I. Zhidkova, K. Yu. Medvedeva, E. E. Pomeshkina, O. E. Filatova, L. A. Chereneva, A. S. Agienko, S. A. Pomeshkina

Publikováno v: The Siberian Journal of Clinical and Experimental Medicine. 37:188-196

Introduction. Despite the contribution of medical advances in improving the citizens’ health status, mortality from cardiovascular diseases (CVD) remains at a high level. In most cases patients seek medical assistance after the disease manifestatio

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::dea51c8d1bf089432d832310b118d010
https://doi.org/10.29001/2073-8552-2022-37-4-188-196

Classic homocystinuria: etiology, natural history and treatment

Autor: E. Filatova, E. Tao, T. Shevtsova, E. Shchegoleva, P. Novikov, N. Bulanov, N. Chebotareva, S. Moiseev

Publikováno v: Clinical pharmacology and therapy. 34:30-37

Classic homocystinuria is a rare autosomal recessive disorder of methionine metabolism resulting from a deificiency of cystathionine beta-synthase that is involved in transsulfuration of homocysteine. The disorder is caused by mutations of CBS gene.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::22e075bea13369a4f5a75989c2e49aac
https://doi.org/10.32756/0869-5490-2022-3-30-37